ADMA logo

ADMA Biologics (ADMA) Selling, General & Administrative Expenses

Annual SG&A

$59.02 M
+$6.56 M+12.51%

31 December 2023

3-Year Change

+37.59%
ADMA annual selling, general & administrative expenses is up +37.59% over the past 3 years

All-time High

$59.02 M
ADMA annual selling, general & administrative expenses is currently at an all-time high

Sector Rank

64.17%
ADMA annual selling, general & administrative expenses is higher than 64.17% of companies in Healthcare sector
Annual Total Expenses$236.58 M
ADMA annual total expenses is $236.58 million
Annual Operating Expenses$67.31 M
ADMA annual total operating expenses is $67.31 million
Annual Revenue$258.21 M
ADMA annual revenue is $258.21 million
Annual Net Income-$28.24 M
ADMA annual net profit is -$28.24 million

ADMA Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$18.56 M
+$1.95 M+11.75%

30 September 2024

1-Year Change

+19.47%
ADMA quarterly selling, general & administrative expenses is up +19.47% year-on-year

3-Year Change

+58.66%
ADMA quarterly selling, general & administrative expenses is up +58.66% over the past 3 years

All-time High

$18.56 M
ADMA quarterly selling, general & administrative expenses is currently at an all-time high

Sector Rank

66.29%
ADMA quarterly selling, general & administrative expenses is higher than 66.29% of companies in Healthcare sector
Quarterly Total Expenses$80.20 M
ADMA quarterly total expenses is $80.20 million
Quarterly Operating Expenses$20.02 M
ADMA quarterly total operating expenses is $20.02 million
Quarterly Revenue$119.84 M
ADMA quarterly revenue is $119.84 million
Quarterly Net Income$35.91 M
ADMA quarterly net profit is $35.91 million

ADMA Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$1.87 B
+$68.13 M+3.51%

30 September 2024

1-Year Change

-3271.03%
ADMA TTM selling, general & administrative expenses is down -3271.03% year-on-year

3-Year Change

-4462.95%
ADMA TTM selling, general & administrative expenses is down -4462.95% over the past 3 years

All-time High

$66.34 M
ADMA TTM selling, general & administrative expenses is currently -2921.10% below its historical high of $66.34 million

Sector Rank

26.86%
ADMA TTM selling, general & administrative expenses is higher than 26.86% of companies in Healthcare sector
Annual Total Expenses$236.58 M
ADMA annual total expenses is $236.58 million
Annual Operating Expenses$67.31 M
ADMA annual total operating expenses is $67.31 million
TTM Revenue$382.81 M
ADMA TTM revenue is $382.81 million
TTM Net Income$68.13 M
ADMA TTM net profit is $68.13 million

ADMA TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+19.5%-3271.0%
3 y3 years+37.6%+58.7%-4462.9%
5 y5 years+127.8%+163.9%-7323.1%

ADMA Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+37.6%at high+58.7%-21.2%+5.2%
5 y5 yearsat high+127.8%at high+163.9%-88.8%+5.2%
alltimeall timeat high>+9999.0%at high>+9999.0%<-9999.0%+5.2%

ADMA Biologics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$18.56 M(+11.8%)
$66.34 M(+6.1%)
June 2024
-
$16.61 M(+6.2%)
$62.51 M(+3.9%)
Mar 2024
-
$15.64 M(+0.7%)
$60.15 M(+1.9%)
Dec 2023
$59.02 M(+12.5%)
$15.54 M(+5.5%)
$59.02 M(+2.9%)
Sept 2023
-
$14.73 M(+3.4%)
$57.38 M(+3.3%)
June 2023
-
$14.25 M(-1.8%)
$55.55 M(+4.3%)
Mar 2023
-
$14.51 M(+4.4%)
$53.27 M(+1.5%)
Dec 2022
$52.46 M(+22.3%)
$13.89 M(+7.8%)
$52.46 M(+4.4%)
Sept 2022
-
$12.89 M(+7.7%)
$50.26 M(+4.5%)
June 2022
-
$11.97 M(-12.6%)
$48.09 M(+3.3%)
Mar 2022
-
$13.70 M(+17.1%)
$46.56 M(+8.5%)
Dec 2021
$42.90 M(+22.4%)
$11.70 M(+9.1%)
$42.90 M(+5.9%)
Sept 2021
-
$10.73 M(+2.8%)
$40.50 M(+4.1%)
June 2021
-
$10.44 M(+4.0%)
$38.89 M(+4.7%)
Mar 2021
-
$10.03 M(+7.9%)
$37.15 M(+6.0%)
Dec 2020
$35.05 M(+35.3%)
$9.30 M(+2.0%)
$35.05 M(+6.9%)
Sept 2020
-
$9.12 M(+4.7%)
$32.78 M(+6.2%)
June 2020
-
$8.70 M(+9.7%)
$30.86 M(+9.3%)
Mar 2020
-
$7.93 M(+12.8%)
$28.25 M(+9.0%)
Dec 2019
$25.91 M(+15.1%)
$7.03 M(-2.3%)
$25.91 M(+3.8%)
Sept 2019
-
$7.20 M(+18.3%)
$24.95 M(+6.5%)
June 2019
-
$6.09 M(+8.8%)
$23.42 M(+2.8%)
Mar 2019
-
$5.60 M(-7.9%)
$22.78 M(+1.2%)
Dec 2018
$22.50 M(+20.0%)
$6.07 M(+7.1%)
$22.50 M(+1.0%)
Sept 2018
-
$5.67 M(+4.3%)
$22.27 M(+7.1%)
June 2018
-
$5.44 M(+2.2%)
$20.80 M(+5.1%)
Mar 2018
-
$5.32 M(-8.9%)
$19.80 M(+5.6%)
Dec 2017
$18.75 M
$5.84 M(+39.3%)
$18.75 M(+15.8%)
Sept 2017
-
$4.20 M(-5.4%)
$16.19 M(+17.5%)
June 2017
-
$4.44 M(+3.7%)
$13.78 M(+24.5%)
DateAnnualQuarterlyTTM
Mar 2017
-
$4.28 M(+30.3%)
$11.06 M(+30.2%)
Dec 2016
$8.49 M(+25.9%)
$3.28 M(+84.6%)
$8.49 M(+19.7%)
Sept 2016
-
$1.78 M(+3.2%)
$7.10 M(-4.0%)
June 2016
-
$1.72 M(+1.0%)
$7.39 M(+4.0%)
Mar 2016
-
$1.71 M(-9.4%)
$7.11 M(+5.4%)
Dec 2015
$6.75 M(+39.8%)
$1.88 M(-9.3%)
$6.75 M(+12.9%)
Sept 2015
-
$2.08 M(+44.6%)
$5.97 M(+21.2%)
June 2015
-
$1.44 M(+6.8%)
$4.93 M(-2.1%)
Mar 2015
-
$1.35 M(+21.0%)
$5.04 M(+4.4%)
Dec 2014
$4.82 M(+10.5%)
$1.11 M(+7.4%)
$4.82 M(+2.4%)
Sept 2014
-
$1.04 M(-32.9%)
$4.71 M(+4.2%)
June 2014
-
$1.54 M(+35.9%)
$4.52 M(+11.1%)
Mar 2014
-
$1.13 M(+13.6%)
$4.07 M(-6.8%)
Dec 2013
$4.37 M(+38.9%)
$998.60 K(+18.1%)
$4.37 M(+7.4%)
Sept 2013
-
$845.30 K(-22.5%)
$4.06 M(-4.4%)
June 2013
-
$1.09 M(-23.8%)
$4.25 M(+9.1%)
Mar 2013
-
$1.43 M(+105.6%)
$3.90 M(+24.1%)
Dec 2012
$3.14 M(>+9900.0%)
$696.20 K(-32.7%)
$3.14 M(+28.3%)
Sept 2012
-
$1.03 M(+40.4%)
$2.45 M(+72.6%)
June 2012
-
$736.90 K(+9.2%)
$1.42 M(+103.5%)
Mar 2012
-
$674.60 K(>+9900.0%)
$697.30 K(+2521.4%)
Dec 2011
-
$3900.00(0.0%)
$26.60 K(0.0%)
Sept 2011
-
$3900.00(-73.8%)
$26.60 K(0.0%)
June 2011
$26.50 K(+29.3%)
$14.90 K(+282.1%)
$26.60 K(+22.6%)
Mar 2011
-
$3900.00(0.0%)
$21.70 K(-0.5%)
Dec 2010
-
$3900.00(0.0%)
$21.80 K(+1.9%)
Sept 2010
-
$3900.00(-61.0%)
$21.40 K(+22.3%)
June 2010
-
$10.00 K(+150.0%)
$17.50 K(+133.3%)
June 2010
$20.50 K
-
-
Mar 2010
-
$4000.00(+14.3%)
$7500.00(+114.3%)
Dec 2009
-
$3500.00
$3500.00

FAQ

  • What is ADMA Biologics annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for ADMA Biologics?
  • What is ADMA Biologics quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for ADMA Biologics?
  • What is ADMA Biologics quarterly SG&A year-on-year change?
  • What is ADMA Biologics TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for ADMA Biologics?
  • What is ADMA Biologics TTM SG&A year-on-year change?

What is ADMA Biologics annual selling, general & administrative expenses?

The current annual SG&A of ADMA is $59.02 M

What is the all time high annual SG&A for ADMA Biologics?

ADMA Biologics all-time high annual selling, general & administrative expenses is $59.02 M

What is ADMA Biologics quarterly selling, general & administrative expenses?

The current quarterly SG&A of ADMA is $18.56 M

What is the all time high quarterly SG&A for ADMA Biologics?

ADMA Biologics all-time high quarterly selling, general & administrative expenses is $18.56 M

What is ADMA Biologics quarterly SG&A year-on-year change?

Over the past year, ADMA quarterly selling, general & administrative expenses has changed by +$3.02 M (+19.47%)

What is ADMA Biologics TTM selling, general & administrative expenses?

The current TTM SG&A of ADMA is -$1.87 B

What is the all time high TTM SG&A for ADMA Biologics?

ADMA Biologics all-time high TTM selling, general & administrative expenses is $66.34 M

What is ADMA Biologics TTM SG&A year-on-year change?

Over the past year, ADMA TTM selling, general & administrative expenses has changed by -$1.93 B (-3271.03%)